Aldevron Acquires Nature Technology Corporation
January 24, 2022
Acquisition combines Aldevron's leadership in GMP manufacturing with Nature Tech's portfolio of proprietary technologies. Aldevron has acquired Nature Technology Corporation (NTC), a developer of innovative and proprietary plasmid constructs and manufacturing solutions that are used in the field of cell and gene therapy. NTC's nucleic acid-based technologies include NanoplasmidTM, a proprietary vector construct that improves [...]
Instron® Introduces New 3400 and 6800 Series Universal Testing Systems
January 24, 2022
New High Force Floor Models Ranging up to 300 kN Building on a 75 year legacy of excellence in mechanical testing, Instron is proud to announce the capacity expansion of the 3400 and 6800 Series universal testing systems. The all-new 3400 and 6800 Series high force universal testing systems are successors to Instron’s popular 3300 and 5900 Series systems [...]
Stira Pharmaceuticals Selects Xybion Digital to Transform Lab Operations
January 24, 2022
Labwise XD LIMS Cloud Solution is being implemented to digitize lab processes to improve efficiencies and improve compliance for Stira Pharmaceuticals VANCOUVER, BC and PRINCETON, NJ / ACCESSWIRE / January 24, 2022 / Xybion Digital (TSXV:XYBN), a global, low-code SaaS company that enables digital transformation in highly regulated industries like Life Sciences, announced today it has [...]
January 24, 2022
This cell culture supplement can be used to manufacture both autologous and allogeneic cell therapies Westbury, NY – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the launch of its Good Manufacturing Practice (GMP) grade human AB serum, a cell culture supplement to enhance the development and manufacturing [...]
NanoMosaic Signs 31K Square Foot Lease and Establishes “Multi-Omics World Headquarters” in Waltham,
January 24, 2022
BOSTON -- NanoMosaic, the pioneer and leader in nanoneedle (MosaicNeedle™) technology detection for proteomics, genomics, and single-run experiment multi-omics applications has announced that it has signed a lease for a standalone building of 30,880 square feet in Waltham, MA. The company's new "Multi-Omics World Headquarters" is strategically located in an emerging and vibrant biotech hub [...]
SeqOne Genomics closes €20M series A to accelerate the deployment of its genomic medicine platform
January 24, 2022
The funding will drive international deployment of the company’s next generation genomic analysis platform to enable personalized medicine in cancers as well as rare and hereditary diseases. Montpellier – SeqOne Genomics, provider of next genomic analysis solutions for personalized medicine today announced a Series A funding round of €20M. The round, led by Omnes, Merieux [...]
January 24, 2022
CloneSelect® Imager FL provides a seamless end-to-end workflow for: High-speed label-free and multi-channel fluorescence full-well image acquisition Intelligent data analysis Monoclonality report generation San Jose, Calif. – Molecular Devices, LLC. , a leading provider of high-performance life science solutions, has officially launched its CloneSelect® Imager FL platform (CSI FL). The CSI FL is capable of imaging and reporting on [...]
Instron® Introduces New 3400 and 6800 Series Universal Testing Systems
January 24, 2022
New High Force Floor Models Ranging up to 300 kN Building on a 75 year legacy of excellence in mechanical testing, Instron is proud to announce the capacity expansion of the 3400 and 6800 Series universal testing systems. The all-new 3400 and 6800 Series high force universal testing systems are successors to Instron’s popular 3300 and 5900 Series systems [...]
Dr Susanne Braum joins INFORS HT as Managing Director for Germany
January 24, 2022
Dr Susanne Braum will join INFORS HT as the Managing Director for its German subsidiary Infors GmbH. Susanne is a seasoned expert in medical and laboratory systems for the international life science industry and her appointment will further strengthen the capability of INFORS HT to serve its German customers. Dr Susanne Braum will take-over the [...]
Illumina collaborates with National Cancer Center Japan to address a leading cause of death in Asia
January 24, 2022
TruSight™ Oncology 500 ctDNA panel to be used across a number of Asian countries to develop personalized cancer treatments for Nasopharyngeal Carcinoma SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) and the National Cancer Center Japan have announced an international joint research project that will use Illumina's high-throughput DNA sequencing to analyse the blood-based genomic profile [...]

